CytoSorbents Announces Board Chairman Al W. Kraus To Retire
PRINCETON, N.J., April 19, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced today that its Chairman of the Board, Al W. Kraus, will retire at the end of his term in early June 2023.
Related news for (CTSO)
- CytoSorbents To Host Global Webinar on “Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb” in Recognition of World Sepsis Day
- CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
- CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
- CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
- MoBot’s Stock Market Highlights – 08/01/25 08:00 AM